scorecardresearch
Add as a preferred source on Google
Monday, December 15, 2025
TopicCovid vaccine

Topic: Covid vaccine

Bharat Biotech wants to test administering Covid vaccine through skin instead of muscle

Intradermal vaccine delivery, if proven effective, could make Covaxin shots cheaper since they require a lesser amount of vaccine, which also means more people can get vaccinated. 

Vaccines use bizarre stuff. We need a supply chain to deal with that now

Vaccine supply chains contain some unusual links, including horseshoe crab blood, shark liver oil and an enzyme that’s one of the world’s most expensive products.

Covid testing, positivity trends since 13 August reassuring, but can’t get lax, says govt

NITI Aayog member Dr V.K. Paul also warned against excessive optimism about the ongoing vaccine trials in India, and said not all candidates that go to trial are successful.

Govt expert group reviews 3 Covid vaccines in clinical trial stage in India

The National Expert Group on Vaccine Administration met with 5 pharmaceutical companies that are developing vaccine candidates in India.

Pros and cons of China’s lead in vaccines, UK govt’s blame game and other global Covid news

As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe.

There are over 175 coronavirus vaccines in the race. But what happens if we don’t get one

A vaccine could provide a way to end the pandemic, but with no prospect of natural herd immunity we could well be facing the threat of Covid-19 for a long time to come.

Russia’s Sputnik launch raises risks in the rush for Covid vaccine

Russia's plan to start mass inoculations as soon as October could put pressure on other governments to rush ahead of regulators and skip key steps, putting people who get the shots at risk.

Don’t expect Covaxin news on 15 August, says Bharat Biotech, phase 1 of ICMR trial still on

Twelve trial sites are testing the ICMR-Bharat Biotech-developed Covid vaccine candidate. Last month, ICMR spurred controversy by setting a 15 Aug-deadline for finishing trial.

Russia is not world’s first to develop Covid vaccine, says Kiran Mazumdar-Shaw

Biocon co-founder Kiran Mazumdar-Shaw also questioned the launch of a vaccine prior to completion of Phase 3 trials, saying if it's acceptable to Russia, so be it.

Russia’s Sputnik vaccine gamble is all about Vladimir Putin

Putin's rushed vaccine endorsement is less an affirmation of Russian scientific prowess than it is an expression of his hankering for Soviet-era international clout.

On Camera

I’ve been driving an EV for 2 years—Indian roads are ready to switch to electric

Driving an electric vehicle for months, the Hyundai IONIQ5, BMW iX and now the Kia Carens Clavis electric, has convinced me of the viability of EVs for city and mid-range commutes.

Rupee’s turmoil has echoes of 2013

With the US-India trade deal yet to get done, rupee depreciation may be helping to mitigate India’s loss of competitiveness. The other problem is extreme despondence among overseas equity investors.

US clears $686-mn package to breathe fresh life into Pakistani F-16s

Of the total package, $649 million will be utilised for additional hardware, software, and support services, and the remaining for Major Defence Equipment (MDE).

India’s top airline just handed sarkar the keys. That’s IndiGo’s real ‘crime’

Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.